Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Shiozaki

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Molecular and Clinical Oncology|March 21, 2014
Early response to neoadjuvant chemotherapy in advanced esophageal cancer evaluated by computed tomography predicts the utility of a second cycle of chemotherapyMasaaki Motoori, Masahiko Yano, Takushi Yasuda, et al.
Oncology|July 11, 2012
Relationship between immunological parameters and the severity of neutropenia and effect of enteral nutrition on immune status during neoadjuvant chemotherapy on patients with advanced esophageal cancerMasaaki Motoori, Masahiko Yano, Takushi Yasuda, et al.
Oncology|July 23, 2011
Multicenter phase I/II study of docetaxel, cisplatin and fluorouracil combination chemotherapy in patients with advanced or recurrent squamous cell carcinoma of the esophagusMakoto Yamasaki, Hiroshi Miyata, Koji Tanaka, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 18, 2011
Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancerHaruhiko Imamoto, Koji Oba, Junichi Sakamoto, et al.
Japanese Journal of Clinical Oncology|March 1, 2013
A Phase I/II trial of radiotherapy concurrent with TS-1 plus cisplatin in patients with clinically resectable type 4 or large type 3 gastric cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1205Motohiro Imano, Hiroshi Furukawa, Masaki Yokokawa, et al.
Oncology|December 22, 2007
Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic imagesYasunori Minami, Masatoshi Kudo, Hobyung Chung, et al.
Oncogene|May 31, 2002
Restoration of E-cadherin-based cell-cell adhesion by overexpression of nectin in HSC-39 cells, a human signet ring cell gastric cancer cell lineYing-Feng Peng, Kenji Mandai, Hiroyuki Nakanishi, et al.
Anticancer Research|April 9, 2013
Establishment of a novel model of peritoneal carcinomatosis of the peritoneal extension typeMotohiro Imano, Tatsuki Itoh, Takao Satou, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 17, 2014
A newly modified esophagogastrostomy with a reliable angle of His by placing a gastric tube in the lower mediastinum in laparoscopy-assisted proximal gastrectomyAtsushi Yasuda, Takushi Yasuda, Haruhiko Imamoto, et al.
Oncotarget|June 17, 2014
Frequent amplification of ORAOV1 gene in esophageal squamous cell cancer promotes an aggressive phenotype via proline metabolism and ROS productionYosuke Togashi, Tokuzo Arao, Hiroaki Kato, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Molecular and Clinical Oncology|March 21, 2014
Early response to neoadjuvant chemotherapy in advanced esophageal cancer evaluated by computed tomography predicts the utility of a second cycle of chemotherapyMasaaki Motoori, Masahiko Yano, Takushi Yasuda, et al.
Oncology|July 11, 2012
Relationship between immunological parameters and the severity of neutropenia and effect of enteral nutrition on immune status during neoadjuvant chemotherapy on patients with advanced esophageal cancerMasaaki Motoori, Masahiko Yano, Takushi Yasuda, et al.
Oncology|July 23, 2011
Multicenter phase I/II study of docetaxel, cisplatin and fluorouracil combination chemotherapy in patients with advanced or recurrent squamous cell carcinoma of the esophagusMakoto Yamasaki, Hiroshi Miyata, Koji Tanaka, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 18, 2011
Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancerHaruhiko Imamoto, Koji Oba, Junichi Sakamoto, et al.
Japanese Journal of Clinical Oncology|March 1, 2013
A Phase I/II trial of radiotherapy concurrent with TS-1 plus cisplatin in patients with clinically resectable type 4 or large type 3 gastric cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1205Motohiro Imano, Hiroshi Furukawa, Masaki Yokokawa, et al.
Oncology|December 22, 2007
Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic imagesYasunori Minami, Masatoshi Kudo, Hobyung Chung, et al.
Oncogene|May 31, 2002
Restoration of E-cadherin-based cell-cell adhesion by overexpression of nectin in HSC-39 cells, a human signet ring cell gastric cancer cell lineYing-Feng Peng, Kenji Mandai, Hiroyuki Nakanishi, et al.
Anticancer Research|April 9, 2013
Establishment of a novel model of peritoneal carcinomatosis of the peritoneal extension typeMotohiro Imano, Tatsuki Itoh, Takao Satou, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 17, 2014
A newly modified esophagogastrostomy with a reliable angle of His by placing a gastric tube in the lower mediastinum in laparoscopy-assisted proximal gastrectomyAtsushi Yasuda, Takushi Yasuda, Haruhiko Imamoto, et al.
Oncotarget|June 17, 2014
Frequent amplification of ORAOV1 gene in esophageal squamous cell cancer promotes an aggressive phenotype via proline metabolism and ROS productionYosuke Togashi, Tokuzo Arao, Hiroaki Kato, et al.
Pageof 9